drugset / Trial / NCT00230698

A Study of the Effectiveness and Safety of Topiramate Monotherapy in Patients With Recently Diagnosed Partial-Onset Seizure

NCT00230698

RandomizedParallel-groupDouble-blindTreatment

Summary

The purposes of this study are (1) to compare the effectiveness of two doses of topiramate and (2) to assess the safety of topiramate alone in the treatment of pediatric and adult patients with recently diagnosed epilepsy characterized by partial-onset seizures.

Timeline

Start
1995-11
Primary completion
Completion
2002-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Topiramate Small molecule 24 mg/kg Oral
Subject Topiramate Small molecule 25 mg Oral
Subject Topiramate Small molecule 50 mg Oral
Subject Topiramate Small molecule 200 mg Oral
Subject Topiramate Small molecule 500 mg Oral
Subject Topiramate Small molecule 1600 mg Oral

Indications